ARCA biopharma Inc (ABIO):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:ARCA biopharma Inc (ABIO) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7847
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ARCA Biopharma Inc (ARCA), formerly Nuvelo Inc is a developer of genetically targeted therapies for cardiovascular diseases. The company’s product candidate include Gencaro, a mild vasodilator and investigational pharmacologically unique beta-blocker that is being developed for the treatment and prevention of atrial fibrillation in patients with heart failure and reduced left ventricular ejection fraction. It provides medical treatment to the individual genetic characteristics of each patient and personalized medicine approach to drug development. ARCA also develops AB171, a thiol-substituted isosorbide mononitrate for genetically targeted treatment of peripheral arterial disease and heart failure. The company works in partnership with universities to improve the health of cardiovascular patients. ARCA is headquartered in Westminster, Colorado, the US.

ARCA biopharma Inc (ABIO) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ARCA biopharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ARCA biopharma Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
ARCA biopharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ARCA biopharma Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
ARCA biopharma Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
ARCA biopharma Inc, Medical Equipment, Deal Details 10
Partnerships 10
Arca Biopharma Extends Co-Development Agreement with Medtronic for Gencaro 10
Equity Offering 11
ARCA biopharma Raises USD0.1 Million in Public Offering of Shares 11
Arca Biopharma Raises USD37 Million in Private Placement of Units 12
ARCA biopharma Inc – Key Competitors 14
ARCA biopharma Inc – Key Employees 15
ARCA biopharma Inc – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Financial Announcements 17
May 08, 2018: ARCA Biopharma announces first quarter 2018 financial results and provides corporate update 17
Mar 22, 2018: ARCA biopharma Announces Fiscal Year 2017 Financial Results and Provides Corporate Update 18
Nov 09, 2017: ARCA biopharma Announces Third Quarter 2017 Financial Results and Provides Business Update 19
Aug 03, 2017: ARCA biopharma Announces Second Quarter 2017 Financial Results and Provides Business Update 20
May 15, 2017: ARCA Biopharma Announces First Quarter 2017 Financial Results 22
Mar 21, 2017: ARCA biopharma Announces Fiscal Year 2016 Financial Results and Provides Business Update 23
Corporate Communications 25
Feb 21, 2017: Anders Hove, MD Joins ARCA biopharma Board of Directors 25
Other Significant Developments 26
Feb 02, 2018: ARCA Biopharma Selects TransPerfect’s Trial Interactive eTMF Solution 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
ARCA biopharma Inc, Medical Equipment, Key Facts, 2017 2
ARCA biopharma Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
ARCA biopharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ARCA biopharma Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
ARCA biopharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ARCA biopharma Inc, Deals By Market, 2012 to YTD 2018 8
ARCA biopharma Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Arca Biopharma Extends Co-Development Agreement with Medtronic for Gencaro 10
ARCA biopharma Raises USD0.1 Million in Public Offering of Shares 11
Arca Biopharma Raises USD37 Million in Private Placement of Units 12
ARCA biopharma Inc, Key Competitors 14
ARCA biopharma Inc, Key Employees 15

List of Figures
ARCA biopharma Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
ARCA biopharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
ARCA biopharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
ARCA biopharma Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
ARCA biopharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ARCA biopharma Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
ARCA biopharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ARCA biopharma Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[ARCA biopharma Inc (ABIO):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • FirstCaribbean International Bank Limited:企業の戦略的SWOT分析
    FirstCaribbean International Bank Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Bessemer Venture Partners:企業のM&A・事業提携・投資動向
    Bessemer Venture Partners - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bessemer Venture Partners Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • TRC Companies Inc:電力:M&Aディール及び事業提携情報
    Summary TRC Companies Inc (TRC Companies) is a construction service provider that offers engineering, consulting and construction management. The company’s services include air quality management, power generation, power delivery engineering, integrity management, energy efficiency, coal ash managem …
  • Treet Corporation Ltd (TREET):企業の財務・戦略的SWOT分析
    Treet Corporation Ltd (TREET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Movado Group, Inc. (MOV):企業の財務・戦略的SWOT分析
    Movado Group, Inc. (MOV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Hayashibara Co Ltd:企業の戦略的SWOT分析
    Hayashibara Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • The Greenbrier Companies, Inc.
    The Greenbrier Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Greenbrier Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Deutsche Telekom AG:戦略・SWOT・企業財務分析
    Deutsche Telekom AG - Strategy, SWOT and Corporate Finance Report Summary Deutsche Telekom AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Hollard Insurance Group:企業の戦略・SWOT・財務分析
    Hollard Insurance Group - Strategy, SWOT and Corporate Finance Report Summary Hollard Insurance Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • MedImmune LLC-製薬・医療分野:企業M&A・提携分析
    Summary MedImmune LLC (MedImmune), a subsidiary of AstraZeneca Plc, is a biotechnology company. It focuses on the research, development, manufacture and marketing of small molecules and biologics to address some of the major medical needs. The company develops therapeutic proteins, monoclonal antibo …
  • Quanta Computer Inc (2382):企業の財務・戦略的SWOT分析
    Quanta Computer Inc (2382) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • SVOGL Oil Gas and Energy Ltd:企業の戦略的SWOT分析
    SVOGL Oil Gas and Energy Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • CompuGroup Medical SE:企業のM&A・事業提携・投資動向
    CompuGroup Medical SE - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's CompuGroup Medical SE Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Falck Renewables S.p.A. (FKR):企業の財務・戦略的SWOT分析
    Falck Renewables S.p.A. (FKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • PROS Holdings Inc (PRO):企業の財務・戦略的SWOT分析
    Summary PROS Holdings Inc (PROS) is an information technology company that offers profitability management and optimization software solutions. The company's products include Selling PRO, Pricing PRO, Revenue PRO and Pros for CRM. Its Selling PRO software comprises e-commerce, Smart CPQ and Deal des …
  • AnGes Inc (4563):企業の財務・戦略的SWOT分析
    AnGes Inc (4563) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Universities Superannuation Scheme Ltd:企業の戦略的SWOT分析
    Universities Superannuation Scheme Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • China National Offshore Oil Corporation:企業のM&A・事業提携・投資動向
    China National Offshore Oil Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China National Offshore Oil Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed re …
  • Singularlogic Information Systems And Software Technology S.A.:企業の戦略的SWOT分析
    Singularlogic Information Systems And Software Technology S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees …
  • King Country Energy Ltd:企業の戦略的SWOT分析
    King Country Energy Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆